Role of lipoprotein(a) in planned heart artery procedures
Part of Heart & circulation clinical trials.
This study looks at whether a type of fat in your blood, called lipoprotein(a), can help predict how well you do after a planned procedure to open a blocked heart artery. If you join, we will take a blood sample before the procedure and follow your recovery to see how lipoprotein(a) levels relate to outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are scheduled for a planned (not emergency) procedure to open a blocked heart artery (PCI)
- You have stable heart artery disease (no recent heart attack or emergency symptoms)
- You are willing to give a small blood sample before the procedure
- You do not have a heart transplant or a mechanical heart pump (LVAD)
- Your doctor expects you to live at least one more year (for reasons unrelated to your heart)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a type of fat in the blood called lipoprotein(a) and your body's ability to break down clots affect heart disease or heart valve disease. It is for people who are already taking certain cholesterol-lowering medicines or have severe aortic valve narrowing from calcium buildup.
This study follows patients who had heart bypass surgery guided by special CT scans and blood flow measurements. Researchers want to understand how well the surgery works and study a blood protein called Lp(a) that may affect heart health.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
This study looks at how a fatty substance in your blood called lipoprotein(a), or Lp(a), might affect the stiffness of your arteries and how well your heart muscle works. It will help us understand if high Lp(a) is connected to early signs of heart disease.
This study looks at whether a blood test for lipoprotein(a) can help predict heart disease risk when combined with a CT scan of the heart. If you are at intermediate risk for heart disease and are having a CT scan, this study may help you understand your risk better.
Hear when a new PCI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.